{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:17:31Z","timestamp":1790572651948,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2025-I2M-XHZY-034"],"award-info":[{"award-number":["2025-I2M-XHZY-034"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["25ZXZSSS00510"],"award-info":[{"award-number":["25ZXZSSS00510"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570713"],"award-info":[{"award-number":["82570713"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470136"],"award-info":[{"award-number":["82470136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341214"],"award-info":[{"award-number":["82341214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41591-026-04366-x","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:03:52Z","timestamp":1777453432000},"page":"2026-2036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1\/2 trial"],"prefix":"10.1038","volume":"32","author":[{"given":"Huiyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7309-8545","authenticated-orcid":false,"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-1028","authenticated-orcid":false,"given":"Rongfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5947-3924","authenticated-orcid":false,"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-2441","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6769-847X","authenticated-orcid":false,"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-7377","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"4366_CR1","doi-asserted-by":"publisher","first-page":"103612","DOI":"10.1016\/j.autrev.2024.103612","volume":"23","author":"M Gatto","year":"2024","unstructured":"Gatto, M., Zen, M., Cruciani, C., Iaccarino, L. & Doria, A. Navigating the landscape of SLE treatment: an expert viewpoint on the rationality and limitations of early biologic intervention. Autoimmun. Rev. 23, 103612 (2024).","journal-title":"Autoimmun. Rev."},{"key":"4366_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/ph16081066","volume":"16","author":"O Gumkowska-Sroka","year":"2023","unstructured":"Gumkowska-Sroka, O., Kotyla, K., Mojs, E., Palka, K. & Kotyla, P. Novel therapeutic strategies in the treatment of systemic sclerosis. Pharmaceuticals 16, 1066 (2023).","journal-title":"Pharmaceuticals"},{"key":"4366_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper, N. & Ghanima, W. Immune thrombocytopenia. N. Engl. J. Med. 381, 945\u2013955 (2019).","journal-title":"N. Engl. J. Med."},{"key":"4366_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41584-024-01210-9","volume":"21","author":"M Stockfelt","year":"2025","unstructured":"Stockfelt, M., Teng, Y. K. O. & Vital, E. M. Opportunities and limitations of B cell depletion approaches in SLE. Nat. Rev. Rheumatol. 21, 111\u2013126 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"4366_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.566732","volume":"11","author":"LS van Dam","year":"2020","unstructured":"van Dam, L. S. et al. Highly sensitive flow cytometric detection of residual B-cells after rituximab in anti-neutrophil cytoplasmic antibodies-associated vasculitis patients. Front. Immunol. 11, 566732 (2020).","journal-title":"Front. Immunol."},{"key":"4366_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaut.2015.05.006","volume":"62","author":"M Mahevas","year":"2015","unstructured":"Mahevas, M. et al. Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab. J Autoimmun. 62, 22\u201330 (2015).","journal-title":"J Autoimmun."},{"key":"4366_CR7","doi-asserted-by":"publisher","first-page":"e153580","DOI":"10.1172\/JCI153580","volume":"132","author":"P Canales-Herrerias","year":"2022","unstructured":"Canales-Herrerias, P. et al. High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura. J. Clin. Invest. 132, e153580 (2022).","journal-title":"J. Clin. Invest."},{"key":"4366_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","volume":"383","author":"L Ostendorf","year":"2020","unstructured":"Ostendorf, L. et al. Targeting CD38 with daratumumab in refractory systemic lupus erythematosus. N. Engl. J. Med. 383, 1149\u20131155 (2020).","journal-title":"N. Engl. J. Med."},{"key":"4366_CR9","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1182\/bloodadvances.2024012585","volume":"8","author":"M Jalink","year":"2024","unstructured":"Jalink, M. et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 8, 2622\u20132634 (2024).","journal-title":"Blood Adv."},{"key":"4366_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00277-022-05035-y","volume":"102","author":"T Strussmann","year":"2023","unstructured":"Strussmann, T. et al. Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab. Ann. Hematol. 102, 245\u2013247 (2023).","journal-title":"Ann. Hematol."},{"key":"4366_CR11","doi-asserted-by":"publisher","first-page":"102724","DOI":"10.1016\/j.bcmd.2023.102724","volume":"99","author":"I Vernava","year":"2023","unstructured":"Vernava, I. & Schmitt, C. A. Daratumumab as a novel treatment option in refractory ITP. Blood Cells Mol. Dis. 99, 102724 (2023).","journal-title":"Blood Cells Mol. Dis."},{"key":"4366_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41409-024-02479-w","volume":"60","author":"S Giammarco","year":"2025","unstructured":"Giammarco, S. et al. The role of daratumumab in complications post-allogeneic hematopoietic stem cell transplantation: a single-center prospective study on PRCA and AIHA. Bone Marrow Transplant. 60, 305\u2013309 (2025).","journal-title":"Bone Marrow Transplant."},{"key":"4366_CR13","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa2400409","volume":"390","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. A novel anti-CD38 monoclonal antibody for treating immune thrombocytopenia. N. Engl. J. Med. 390, 2178\u20132190 (2024).","journal-title":"N. Engl. J. Med."},{"key":"4366_CR14","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMc2501527","volume":"392","author":"T Sun","year":"2025","unstructured":"Sun, T., Chen, Y. & Zhang, L. Daratumumab in relapsed or refractory pediatric immune thrombocytopenia. N. Engl. J. Med. 392, 2069\u20132071 (2025).","journal-title":"N. Engl. J. Med."},{"key":"4366_CR15","doi-asserted-by":"publisher","first-page":"e003604","DOI":"10.1136\/rmdopen-2023-003604","volume":"9","author":"MT Holzer","year":"2023","unstructured":"Holzer, M. T. et al. Daratumumab for autoimmune diseases: a systematic review. RMD Open 9, e003604 (2023).","journal-title":"RMD Open"},{"key":"4366_CR16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jaci.2022.01.025","volume":"149","author":"IM Otani","year":"2022","unstructured":"Otani, I. M. et al. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. J. Allergy Clin. Immunol. 149, 1525\u20131560 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"4366_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41586-023-05720-6","volume":"615","author":"A Hooftman","year":"2023","unstructured":"Hooftman, A. et al. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production. Nature 615, 490\u2013498 (2023).","journal-title":"Nature"},{"key":"4366_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13559-7","volume":"10","author":"JF Ziegler","year":"2019","unstructured":"Ziegler, J. F. et al. Leptin induces TNF\u03b1-dependent inflammation in acquired generalized lipodystrophy and combined Crohn\u2019s disease. Nat. Commun. 10, 5629 (2019).","journal-title":"Nat. Commun."},{"key":"4366_CR19","doi-asserted-by":"publisher","first-page":"e200013","DOI":"10.20900\/immunometab20200013","volume":"2","author":"X Zheng","year":"2020","unstructured":"Zheng, X., Tsou, P. S. & Sawalha, A. H. Increased expression of EZH2 is mediated by higher glycolysis and mTORC1 activation in lupus CD4+ T cells. Immunometabolism 2, e200013 (2020).","journal-title":"Immunometabolism"},{"key":"4366_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05641-2","volume":"14","author":"J Wei","year":"2023","unstructured":"Wei, J. et al. Elevated fatty acid \u03b2-oxidation by leptin contributes to the proinflammatory characteristics of fibroblast-like synoviocytes from RA patients via LKB1-AMPK pathway. Cell Death Dis. 14, 97 (2023).","journal-title":"Cell Death Dis."},{"key":"4366_CR21","doi-asserted-by":"publisher","first-page":"1396827","DOI":"10.3389\/fimmu.2024.1396827","volume":"15","author":"TM Legroux","year":"2024","unstructured":"Legroux, T. M. et al. Immunomodulation by glucocorticoid-induced leucine zipper in macrophages: enhanced phagocytosis, protection from pyroptosis, and altered mitochondrial function. Front. Immunol. 15, 1396827 (2024).","journal-title":"Front. Immunol."},{"key":"4366_CR22","doi-asserted-by":"publisher","first-page":"e166795","DOI":"10.1172\/JCI166795","volume":"134","author":"X Li","year":"2024","unstructured":"Li, X. et al. Excess glucocorticoids inhibit murine bone turnover via modulating the immunometabolism of the skeletal microenvironment. J. Clin. Invest. 134, e166795 (2024).","journal-title":"J. Clin. Invest."},{"key":"4366_CR23","doi-asserted-by":"publisher","first-page":"106929","DOI":"10.1016\/j.phrs.2023.106929","volume":"196","author":"PXL Gan","year":"2023","unstructured":"Gan, P. X. L., Liao, W., Lim, H. F. & Wong, W. S. F. Dexamethasone protects against Aspergillus fumigatus-induced severe asthma via modulating pulmonary immunometabolism. Pharmacol. Res. 196, 106929 (2023).","journal-title":"Pharmacol. Res."},{"key":"4366_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-07282-7","volume":"629","author":"JP Auger","year":"2024","unstructured":"Auger, J. P. et al. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature 629, 184\u2013192 (2024).","journal-title":"Nature"},{"key":"4366_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cmet.2023.05.001","volume":"35","author":"BJ Jenkins","year":"2023","unstructured":"Jenkins, B. J. et al. Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity. Cell Metab. 35, 1132\u20131146 (2023).","journal-title":"Cell Metab."},{"key":"4366_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/art.42724","volume":"76","author":"EN Montano","year":"2024","unstructured":"Montano, E. N. et al. \u03b1-Ketoglutarate\u2212dependent KDM6 histone demethylases and interferon-stimulated gene expression in lupus. Arthritis Rheumatol. 76, 396\u2013410 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"4366_CR27","doi-asserted-by":"publisher","first-page":"114379","DOI":"10.1016\/j.celrep.2024.114379","volume":"43","author":"W Pan","year":"2024","unstructured":"Pan, W., Tsokos, M. G., Scherlinger, M., Li, W. & Tsokos, G. C. The PP2A regulatory subunit PPP2R2A controls NAD+ biosynthesis to regulate T cell subset differentiation in systemic autoimmunity. Cell Rep. 43, 114379 (2024).","journal-title":"Cell Rep."},{"key":"4366_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110357","volume":"268","author":"S Masuyama","year":"2024","unstructured":"Masuyama, S. et al. Enhanced fatty acid oxidation by selective activation of PPAR\u03b1 alleviates autoimmunity through metabolic transformation in T-cells. Clin. Immunol. 268, 110357 (2024).","journal-title":"Clin. Immunol."},{"key":"4366_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03270-w","volume":"21","author":"S Angiari","year":"2024","unstructured":"Angiari, S. et al. Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation. J. Neuroinflammation 21, 287 (2024).","journal-title":"J. Neuroinflammation"},{"key":"4366_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41392-023-01499-0","volume":"8","author":"N Jia","year":"2023","unstructured":"Jia, N. et al. Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms. Signal Transduct. Target. Ther. 8, 280 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"4366_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211310119","volume":"119","author":"T Meyer","year":"2022","unstructured":"Meyer, T. et al. NAD+ metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity. Proc. Natl Acad. Sci. USA 119, e2211310119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4366_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/art.42351","volume":"75","author":"P Gil Alabarse","year":"2023","unstructured":"Gil Alabarse, P., Chen, L. Y., Oliveira, P., Qin, H. & Liu-Bryan, R. Targeting CD38 to suppress osteoarthritis development and associated pain after joint injury in mice. Arthritis Rheumatol. 75, 364\u2013374 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"4366_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias, A. J., Perrone, R., Grozio, A. & Verdin, E. NAD+ metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 22, 119\u2013141 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4366_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-018-0255-3","volume":"20","author":"PS Minhas","year":"2019","unstructured":"Minhas, P. S. et al. Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation. Nat. Immunol. 20, 50\u201363 (2019).","journal-title":"Nat. Immunol."},{"key":"4366_CR35","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/jth.13767","volume":"15","author":"Q Feng","year":"2017","unstructured":"Feng, Q. et al. High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia. J. Thromb. Haemost. 15, 1845\u20131858 (2017).","journal-title":"J. Thromb. Haemost."},{"key":"4366_CR36","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/scd.2023.0154","volume":"32","author":"Z Liang","year":"2023","unstructured":"Liang, Z. et al. Mesenchymal stromal cells regulate M1\/M2 macrophage polarization in mice with immune thrombocytopenia. Stem Cells Dev. 32, 703\u2013714 (2023).","journal-title":"Stem Cells Dev."},{"key":"4366_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-021-00627-y","volume":"6","author":"HY Zhao","year":"2021","unstructured":"Zhao, H. Y. et al. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity. Signal Transduct. Target. Ther. 6, 234 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"4366_CR38","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1038\/sj.onc.1208842","volume":"24","author":"H Kasperczyk","year":"2005","unstructured":"Kasperczyk, H. et al. Betulinic acid as new activator of NF-\u03baB: molecular mechanisms and implications for cancer therapy. Oncogene 24, 6945\u20136956 (2005).","journal-title":"Oncogene"},{"key":"4366_CR39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1161\/ATVBAHA.120.315650","volume":"41","author":"TY Tien","year":"2021","unstructured":"Tien, T. Y. et al. Reduction of connexin 43 attenuates angiogenic effects of human smooth muscle progenitor cells via inactivation of Akt and NF-\u03baB pathway. Arterioscler. Thromb. Vasc. Biol. 41, 915\u2013930 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"4366_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s44466-025-00014-0","volume":"1","author":"A Hoffmann","year":"2025","unstructured":"Hoffmann, A., Cheng, G. & Baltimore, D. NF-\u03baB: master regulator of cellular responses in health and disease. Immun. Inflamm. 1, 2 (2025).","journal-title":"Immun. Inflamm."},{"key":"4366_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s44466-025-00001-5","volume":"1","author":"J Liu","year":"2025","unstructured":"Liu, J., Chen, Y. & O\u2019 Neill, L. Phospholipid metabolism in innate immunity and inflammation: from basic to clinic. Immun. Inflamm. 1, 6 (2025).","journal-title":"Immun. Inflamm."},{"key":"4366_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1507\/endocrj.EJ19-0313","volume":"67","author":"J Irie","year":"2020","unstructured":"Irie, J. et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr. J. 67, 153\u2013160 (2020).","journal-title":"Endocr. J."},{"key":"4366_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmet.2018.02.001","volume":"27","author":"SJ Mitchell","year":"2018","unstructured":"Mitchell, S. J. et al. Nicotinamide improves aspects of healthspan, but not lifespan, in mice. Cell Metab. 27, 667\u2013676 (2018).","journal-title":"Cell Metab."},{"key":"4366_CR44","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"372","author":"M Yoshino","year":"2021","unstructured":"Yoshino, M. et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 372, 1224\u20131229 (2021).","journal-title":"Science"},{"key":"4366_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq4145","volume":"16","author":"A Malique","year":"2024","unstructured":"Malique, A. et al. NAD+ precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunction. Sci. Transl. Med. 16, eabq4145 (2024).","journal-title":"Sci. Transl. Med."},{"key":"4366_CR46","doi-asserted-by":"publisher","first-page":"e0145342","DOI":"10.1371\/journal.pone.0145342","volume":"10","author":"KA Jablonski","year":"2015","unstructured":"Jablonski, K. A. et al. Novel markers to delineate murine M1 and M2 macrophages. PLoS ONE 10, e0145342 (2015).","journal-title":"PLoS ONE"},{"key":"4366_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2021.10.010","volume":"581","author":"S Wen","year":"2021","unstructured":"Wen, S., Arakawa, H. & Tamai, I. CD38 activation by monosodium urate crystals contributes to inflammatory responses in human and murine macrophages. Biochem. Biophys. Res. Commun. 581, 6\u201311 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"4366_CR48","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/cells13231971","volume":"13","author":"W Lory","year":"2024","unstructured":"Lory, W. et al. CD38 inhibitor 78c attenuates pro-inflammatory cytokine expression and osteoclastogenesis in macrophages. Cells 13, 1971 (2024).","journal-title":"Cells"},{"key":"4366_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103336","volume":"77","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Deletion of CD38 mitigates the severity of NEC in experimental settings by modulating macrophage-mediated inflammation. Redox Biol. 77, 103336 (2024).","journal-title":"Redox Biol."},{"key":"4366_CR50","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1182\/blood.V77.9.1884.1884","volume":"77","author":"JB Bussel","year":"1991","unstructured":"Bussel, J. B. et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood 77, 1884\u20131893 (1991).","journal-title":"Blood"},{"key":"4366_CR51","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1182\/blood-2014-06-582346","volume":"124","author":"M Khellaf","year":"2014","unstructured":"Khellaf, M. et al. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients. Blood 124, 3228\u20133236 (2014).","journal-title":"Blood"},{"key":"4366_CR52","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","volume":"107","author":"CM Bennett","year":"2006","unstructured":"Bennett, C. M. et al. Prospective phase 1\/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 107, 2639\u20132642 (2006).","journal-title":"Blood"},{"key":"4366_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12950-025-00457-7","volume":"22","author":"R Mann","year":"2025","unstructured":"Mann, R., Stavrou, V. & Dimeloe, S. NAD + metabolism AND function in innate AND adaptive immune cells. J. Inflamm. 22, 30 (2025).","journal-title":"J. Inflamm."},{"key":"4366_CR54","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/bph.15477","volume":"179","author":"MN Navarro","year":"2022","unstructured":"Navarro, M. N., G\u00f3mez de Las Heras, M. M. & Mittelbrunn, M. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing. Br. J. Pharmacol. 179, 1839\u20131856 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"4366_CR55","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1111\/bjh.19820","volume":"205","author":"J Li","year":"2024","unstructured":"Li, J. et al. Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia. Br. J. Haematol. 205, 2432\u20132441 (2024).","journal-title":"Br. J. Haematol."},{"key":"4366_CR56","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1073\/pnas.2000943117","volume":"117","author":"C Jing","year":"2020","unstructured":"Jing, C. et al. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc. Natl Acad. Sci. USA 117, 15160\u201315171 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4366_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrrheum.2016.132","volume":"12","author":"CM Cuda","year":"2016","unstructured":"Cuda, C. M., Pope, R. M. & Perlman, H. The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases. Nat. Rev. Rheumatol. 12, 543\u2013558 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"4366_CR58","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert, C. et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 3, 3829\u20133866 (2019).","journal-title":"Blood Adv."},{"key":"4366_CR59","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1537-2995.2009.02558.x","volume":"50","author":"Y Katsman","year":"2010","unstructured":"Katsman, Y., Foo, A. H., Leontyev, D. & Branch, D. R. Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction. Transfusion 50, 1285\u20131294 (2010).","journal-title":"Transfusion"},{"key":"4366_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"4366_CR61","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"4366_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"4366_CR63","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"4366_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16041","volume":"8","author":"K Buscher","year":"2017","unstructured":"Buscher, K. et al. Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survival. Nat. Commun. 8, 16041 (2017).","journal-title":"Nat. Commun."},{"key":"4366_CR65","doi-asserted-by":"publisher","first-page":"109955","DOI":"10.1016\/j.celrep.2021.109955","volume":"37","author":"L He","year":"2021","unstructured":"He, L. et al. Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors. Cell Rep. 37, 109955 (2021).","journal-title":"Cell Rep."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04366-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04366-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04366-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:02:54Z","timestamp":1781791374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04366-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4366"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04366-x","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}